NAS100 29,368 +0.91% S&P 7,657 +0.86% GOLD $4,335 −0.73% BTC $77,927 +1.42% VIX 17.60 +11.11% live tape · as of 13:00 UTC

Vol. II · No. 257Monday, 14 September 2026

TTitan Protect

The Screen · Healthcare

Nano-X Imaging Ltd.

NNOX · Nasdaq · USD · Market cap $127M

FAIL · Does not pass the screen

1.93 USD

At the last full screen
2026-05-22

Screened 2026-05-22 · the tape above runs as of 13:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

The Label · The Season, Not the Day

This name holds its distribution label.

Nano-X Imaging Ltd. holds its Distribution at $1.93. Consolidating, no directional conviction, held for 2 days.

As held on the ledger · 2026-05-22
Phase	Distribution · caution
Quantitative state	Consolidating, no directional conviction, held for 2 days
Price at the screen	$1.93
Valuation	0.00 trailing · -9.10 forward price to earnings
Values screen	FAIL

The Workings

Five Screens, Shown in Full

Does not pass. Cash ratio

Test	Figure	Limit	What it means	Status
Business activity	Permissible	Core business clean	Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.	Pass
Debt load	6.20%	Below 33%	Interest-bearing debt is just 6.2% of its assets, well under the one-third ceiling: it does not run on borrowed money.	Pass
Interest-bearing cash	47.07%	Below 33%	Interest-bearing cash and securities are 47.1% of assets, above the one-third limit.	Fail
Receivables	0.00%	Below 49%	Money owed to the company is 0.0% of assets, under the 49% limit.	Pass
Revenue purity	0.00%	Below 5%	Only 0.0% of revenue comes from non-compliant sources, under the 5% line.	Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Business, in Plain Words

The fundamentals · plain-English read
Forward P/E	-9.1x
Trailing P/E	0.0x
EPS, trailing	-1.16
EPS, forward	-0.20
Revenue growth	+24.0%strong top-line growth
Profit margin	0.0%currently unprofitable
Return on equity	-45.6%not currently earning a positive return on equity
Debt to equity	0.06minimal debt: a conservative balance sheet
Market cap	$127M

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

NNOX trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

How This Name Scores

Drawn as found · screen of 2026-05-22

Confirmed 0 Forming 3 Broken 2

PHPhase · the trend structure carries the Distribution label
INInsiders · no filings inside 60 days, left as found
POPositioning · no disclosures inside 60 days, left as found
OPOptions · no verdict drawn today, left as found
SCScreen · does not pass the values gate

Each arm is one independent read, drawn as found. Conviction is not a single call; it is how many edges converge.

The Scores, As Computed

33.8Quality score
margins, returns, moat
33.0Valuation score
price against the range
37.2Combined
screen of 2026-05-22

The Trader Read

The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 71%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (3 analysts) rates it strong buy, with a mean price target of $7. Entered 2026-09-06 · Markdown

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-09-06 Markdown · changed $1.93 +0.0% Entry 5

2026-08-07 Distribution · changed $1.93 +0.0% Entry 4

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 71%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (3 analysts) rates it strong buy, with a mean price target of $7.

2026-07-18 Markup $1.93 +0.0% Entry 3

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 71%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (3 analysts) rates it strong buy, with a mean price target of $7.

2026-07-03 Markup $1.93 +0.0% Entry 2

2026-07-02 Markup $1.93 Entry 1

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

The Insider Ledger · Form 4 Filings, As Filed

Most recent filings · NNOX
Date	Insider	Title	Type	Shares	Value
2025-09-05	DANIEL RAN	Chief Financial Officer		1,000	$3,650

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The Political Ledger · Congressional Disclosures

Disclosures naming NNOX
Date	Politician	Party	Type	Amount
3 Aug2026	Ro Khanna	Democrat	sell	1K–15K
10 Aug2026	Ro Khanna	Democrat	buy	1K–15K
1 May2026	Ro Khanna	Democrat	buy	1K–15K

What Holding Actually Paid · Price Plus Dividends

If $1,000 had been placed · historical, not a promise
Period	Price then	Price return	Divs per share	$1,000 became	Total return
1 month	$1.63	-0.3%	·	$997	-0.3%
2 months	$2.27	-28.4%	·	$716	-28.4%
3 months	$2.58	-37.0%	·	$630	-37.0%
6 months	$3.34	-51.4%	·	$487	-51.4%
1 year	$5.63	-71.1%	·	$289	-71.1%
2 years	$7.48	-78.3%	·	$217	-78.3%
3 years	$18.56	-91.2%	·	$88	-91.2%
5 years	$29.67	-94.5%	·	$55	-94.5%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever NNOX does next, these words stay.

Nano-X Imaging Ltd. · NNOX · Distribution · $1.93
Recorded 2026-05-22 · before the outcome · scored mechanically

All of today's entries → See the running score →

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.